Literature DB >> 23151790

Sialyl Lewis x expression in cervical scrapes of premalignant lesions.

Noé Velázquez-Márquez1, Gerardo Santos-López, Lucio Jiménez-Aranda, Julio Reyes-Leyva, Verónica Vallejo-Ruiz.   

Abstract

Sialylated oligosaccharides of glycoproteins and glycolipids have been implicated in tumour progression and metastases. Altered expression of glycosidic antigens has been reported in cervical cancer. In cervix premalignant lesions, an increased expression of sialic acid has been reported. In the present study we determined the expression profiles of the glycosidic antigens Tn, sialyl Tn (sTn), Lewis a (Lea), sialyl Lewis a (sLea), Lewis x (Lex) and sialyl Lewis x (sLex) in cervical scrapes with cytological diagnoses of normal, low-grade squamous intraepithelial lesions (LGSIL) and highgrade squamous intraepithelial lesions (HGSIL). Cervical scrapings were collected to detect tumour antigens expressions by flow cytometry using monoclonal antibodies. Cytometry analysis of Tn, sTn, Lea and Lex did not reveal differences at the expression level among groups. The number of positive cells to sLea antigen increased in the HGSIL group with respect to the normal group (p=0.0495). The number of positive cells to sLex antigen in the samples increased with respect to the grade of squamous intraepithelial lesion (SIL) (p less than 0.001, Mann-Whitney U test). The intensity of expression of this antigen increased in the HGSIL samples with respect to normal samples (p less than 0.0068). sLex antigen could be a candidate to be used as biomarker for the early diagnosis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151790     DOI: 10.1007/s12038-012-9261-z

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  38 in total

1.  Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.

Authors:  S D Hoff; Y Matsushita; D M Ota; K R Cleary; T Yamori; S Hakomori; T Irimura
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

2.  Detection of cancer cervix by estimation of sialic acid.

Authors:  Anita Roy; Somajita Chakraborty
Journal:  J Indian Med Assoc       Date:  2005-11

3.  Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients.

Authors:  Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masa-Aki Jibiki; Atsushi Nanashima; Hiroyuki Yamaguchi; Toru Yasutake; Hiroyoshi Ayabe; Kokichi Arisawa; Hiroshi Ishikawa
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

4.  Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias.

Authors:  Richard Ratei; Leonid Karawajew; Richard Schabath; Angelika Ehrfeldt; Fritz Grunert; Wolf-Dieter Ludwig
Journal:  Int J Hematol       Date:  2008-02-27       Impact factor: 2.490

5.  Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.

Authors:  M Ono; M Sakamoto; Y Ino; Y Moriya; K Sugihara; T Muto; S Hirohashi
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

Review 6.  N-Glycans in cancer progression.

Authors:  Ken S Lau; James W Dennis
Journal:  Glycobiology       Date:  2008-08-13       Impact factor: 4.313

Review 7.  Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.

Authors:  Maciej Ugorski; Anna Laskowska
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

8.  Role of sialyl Lewis X in liver metastasis in view of liver-associated immunity.

Authors:  Kiyotaka Okuno; Isao Kawai; Norihiko Hirai; Hisashi Narimatsu; Masayuki Yasutomi
Journal:  Hepatogastroenterology       Date:  2003 May-Jun

9.  Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence.

Authors:  Fania S Doekhie; Hans Morreau; Geertruida H de Bock; Frank M Speetjens; N Geeske Dekker-Ensink; Hein Putter; Cornelis J H van de Velde; Rob A E M Tollenaar; Peter J K Kuppen
Journal:  Cancer Microenviron       Date:  2008-08-06

10.  Losses of expression of the antigens A, Lea and Lex and over-expression of Ley in carcinomas and HG-SIL of the uterine cervix.

Authors:  Ernesto Moro-Rodríguez; Emilio Alvarez-Fernández
Journal:  Diagn Pathol       Date:  2008-09-11       Impact factor: 2.644

View more
  4 in total

Review 1.  Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment.

Authors:  Anna Y Berghuis; Johan F A Pijnenborg; Thomas J Boltje; Johanna M A Pijnenborg
Journal:  Int J Cancer       Date:  2021-11-17       Impact factor: 7.316

2.  Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.

Authors:  Patricia Martinez-Morales; Irene Morán Cruz; Lorena Roa-de la Cruz; Paola Maycotte; Juan Salvador Reyes Salinas; Victor Javier Vazquez Zamora; Claudia Teresita Gutierrez Quiroz; Alvaro Jose Montiel-Jarquin; Verónica Vallejo-Ruiz
Journal:  PeerJ       Date:  2021-08-31       Impact factor: 2.984

3.  Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes.

Authors:  Miguel Aco-Tlachi; Ricardo Carreño-López; Patricia L Martínez-Morales; Paola Maycotte; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez; Gerardo Santos-López; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  Infect Agent Cancer       Date:  2018-07-20       Impact factor: 2.965

4.  Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.

Authors:  Denisse Cisneros-Ramírez; Ygnacio Martínez-Laguna; Patricia Martínez-Morales; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez; Gerardo Santos-López; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  Mol Med Rep       Date:  2020-10-23       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.